Rx (Prescription Medicine)
USD $ 120.00
Cresp 200mcg Injection 是一种用于刺激体内红细胞生成的药物。其活性成分为达伯泊西汀（Darbepoetin alfa），是一种合成的促红细胞生成素（erythropoietin）形式。达伯泊西汀通过与骨髓中红细胞前体细胞上的促红细胞生成素受体结合，促进其增殖与分化为成熟的红细胞。这一过程提高了血液的携氧能力。
Cresp 200mcg Injection 主要用于治疗与慢性肾病（CKD）相关的贫血，适用于接受血液透析和未接受血液透析的患者。它也用于治疗接受化疗的成人癌症患者的贫血。Cresp 200mcg Injection 的剂量和用法应由医疗专业人员根据个体患者的病情、血红蛋白水平及治疗反应来决定。通常通过皮下或静脉给药。
常见副作用可能包括头痛、恶心、呕吐、腹泻以及注射部位疼痛。更严重的副作用如高血压、血栓及过敏反应也可能发生。患者应告知医生任何既往病史，尤其是心血管疾病或癫痫史。Cresp 200mcg Injection 应储存在2°C至8°C（36°F至46°F）之间，并避免光照。不可冷冻。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Darbepoetin Alfa 200 mcg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
